Ono Pharmaceutical and EVQLV collaborate on antibody drug development
Both firms will use EVQLV's proprietary artificial intelligence-powered Antibody Design Engine to generate novel antibodies against multiple targets…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Dec 23
Both firms will use EVQLV's proprietary artificial intelligence-powered Antibody Design Engine to generate novel antibodies against multiple targets…
22 Dec 23
Through the new collaboration, ImmunoScape and EDDC will jointly develop novel off-the-shelf TCR-based bispecific molecules using ImmunoScape’s database…
22 Dec 23
The programme aims to design a potential best in class molecule by combining Exscientia's research platform with Sanofi's…
22 Dec 23
Enrollment in the phase 2 study of acazicolcept in systemic lupus erythematosus (Synergy) will be stopped to allow…
21 Dec 23
The regular approval from the US regulator pertains to the use of the B-cell immunomodulator to mitigate the…
21 Dec 23
Under the agreement, GSK will gain exclusive worldwide rights to progress the clinical development and commercialisation of the…
21 Dec 23
Initially established on 28 March 2022, the agreement between JCR and Takeda focused on joint research and development…
21 Dec 23
Since its establishment in 2020, the Indiana-based biopharmaceutical company has raised a total of $157m funding, with $37m…
20 Dec 23
The joint research venture entitled, New Strategies to Engage Neutrophils in Solid Tumors, is intended to develop immunotherapies…
20 Dec 23
V116, which is intended to be administered as a single dose, is designed to specifically mitigate the risk…